Alnylam Pharmaceuticals, Inc.
ALNY · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $3.71B | $2.25B | +65.2% |
| Operating income | $502M | −$177M | |
| Net income | $314M | −$278M |
Questions
- What was Alnylam's revenue in FY2025?
- $3.71B in FY2025 (Fiscal year ended Dec 31, 2025), +65.2% vs $2.25B a year earlier, per its 10-K filed Feb 2026.
- Was Alnylam profitable in FY2025?
- Yes: net income was $314M and operating income $502M in FY2025.